当前位置：
X-MOL 学术
›
Int. J. Clin. Oncol.
›
论文详情
Our official English website, www.x-mol.net, welcomes your
feedback! (Note: you will need to create a separate account there.)
Changing pattern of tumor markers in recurrent colorectal cancer patients before surgery to recurrence: serum p53 antibodies, CA19-9 and CEA.
International Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2019-12-09 , DOI: 10.1007/s10147-019-01597-6 Mitsunori Ushigome 1 , Hideaki Shimada 1, 2 , Yasuyuki Miura 1 , Kimihiko Yoshida 1 , Tomonori Kaneko 1 , Takamaru Koda 1 , Yasuo Nagashima 1 , Takayuki Suzuki 1 , Satoru Kagami 1 , Kimihiko Funahashi 1
International Journal of Clinical Oncology ( IF 2.4 ) Pub Date : 2019-12-09 , DOI: 10.1007/s10147-019-01597-6 Mitsunori Ushigome 1 , Hideaki Shimada 1, 2 , Yasuyuki Miura 1 , Kimihiko Yoshida 1 , Tomonori Kaneko 1 , Takamaru Koda 1 , Yasuo Nagashima 1 , Takayuki Suzuki 1 , Satoru Kagami 1 , Kimihiko Funahashi 1
Affiliation
The clinical impact of monitoring serum p53 antibodies, carbohydrate antigen19-9, and carcinoembryonic antigen in patients with colorectal cancer has not been fully evaluated.
中文翻译：
复发性大肠癌患者手术复发前肿瘤标志物的变化模式：血清p53抗体，CA19-9和CEA。
尚未全面评估监测血清p53抗体，碳水化合物抗原19-9和癌胚抗原对大肠癌的临床影响。
更新日期：2020-01-04
中文翻译：
复发性大肠癌患者手术复发前肿瘤标志物的变化模式：血清p53抗体，CA19-9和CEA。
尚未全面评估监测血清p53抗体，碳水化合物抗原19-9和癌胚抗原对大肠癌的临床影响。
京公网安备 11010802027423号